Rifaximin Reduces Risk of All-Cause Hospitalization in Cirrhotic Liver Transplant Candidates with Hepatic Encephalopathy

In cirrhotic patients listed for liver transplantation (LT) with a history of hepatic encephalopathy (HE), rifaximin reduces the number of hospitalizations, but whether it influences the time to first hospitalization is unknown. Aims: to evaluate the time-dependent impact of rifaximin on the risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Parisse, Simona, Lai, Quirino, Martini, Francesca, Martini, Alice, Ferri, Flaminia, Mischitelli, Monica, Melandro, Fabio, Mennini, Gianluca, Rossi, Massimo, Alvaro, Domenico, Ginanni Corradini, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647372/
https://www.ncbi.nlm.nih.gov/pubmed/37959336
http://dx.doi.org/10.3390/jcm12216871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647372/
https://www.ncbi.nlm.nih.gov/pubmed/37959336
http://dx.doi.org/10.3390/jcm12216871

Ejemplares similares